live

UK MVS Operating normally
+44 (0) 20 3855 0656
MENU

live

UK MVS Operating normally

How can we help?

Quick Links

End User Registration Guidance

How to progress an alert investigation

EU Exit and UK MVS

How to register as an MAH

First Login - Quick Start Guide

List of Software Suppliers

Should we contact SecurMed to infiliate to GS1?

No. Please contact GS1 directly.

Related articles

EU Exit and UK MVS

The United Kingdom formally departed from the European Union on 31st January 2020, entering into a Transition Period lasting until 31st December 2020.

First Login to UK MVS - Quick Start Guide - Step 1

Ready to log in to the UK MVS? Please follow the links to instructions below.

Does Article 37(d) require that a National Medicine Verification Organisation (NMVO) directly alerts the relevant national competent authorities, the EMA and the Commission about a falsification? Is there is a time limit for such alerting?

The use of the term “provide for” in Article 37(d) of Commission Delegated Regulation (EU) 2016/161 means that an NMVO has to ensure that the National Competent Authorities (NCA), the EMA and the Commission are informed.

Where can I find a copy of the Delegated Regulation?

You can find the Delegated Regulation here.

Which medicines are in scope of FMD?

For details of the scope of the regulation please check: FMD Delegated Regulation 2016_161

Where stakeholders are unclear on the legislation, for example whether types of medicine are in/out of scope, please contact DHSC/MHRA at fmd. safetyfeatures@mhra. gov. uk.

My company has not yet submitted to the MHRA White List of products exempt from FMD charges. Can products still be added to the White List?

Yes. Article 46 of the Delegated Regulation (DR) notifies the commission of additional medicinal products that are at risk or not at risk of falsification. All submissions must be made by the MHRA. Please contact the MHRA for information on how to submit.